Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease

BACKGROUND: Cell replacement therapy (CRT) for Huntington disease (HD) requires a source of striatal (STR) progenitors capable of restoring the function lost due to STR degeneration. Authentic STR progenitors can be collected from the fetal putative striatum, or whole ganglionic eminence (WGE), but...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cytotherapy
Egile Nagusiak: Choompoo, Narawadee, Bartley, Oliver J.M., Precious, Sophie V., Vinh, Ngoc-nga, Schnell, Christian, Garcia, Ana, Roberton, Victoria H., Williams, Nigel M., Kemp, Paul J., Kelly, Claire M., Rosser, Anne E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2021
Gaiak:
Short Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7822401/
https://ncbi.nlm.nih.gov/pubmed/33246883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2020.06.001
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak